239 related articles for article (PubMed ID: 7706704)
1. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects.
Mykkänen L; Kuusisto J; Pyörälä K; Laakso M; Haffner SM
J Hypertens; 1994 Dec; 12(12):1425-32. PubMed ID: 7706704
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL
N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048
[TBL] [Abstract][Full Text] [Related]
3. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.
Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
Diabetes; 1990 Nov; 39(11):1430-5. PubMed ID: 2227116
[TBL] [Abstract][Full Text] [Related]
4. Incidence of diabetes during antihypertensive treatment.
Bengtsson C
Horm Metab Res Suppl; 1990; 22():38-42. PubMed ID: 1975245
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
Bangalore S; Parkar S; Grossman E; Messerli FH
Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
[TBL] [Abstract][Full Text] [Related]
6. Body mass index, blood pressure, diabetes and the risk of anti-hypertensive drug treatment: 12-year follow-up of middle-aged people in eastern Finland.
Jousilahti P; Tuomilehto J; Vartiainen E; Valle T; Nissinen A
J Hum Hypertens; 1995 Oct; 9(10):847-54. PubMed ID: 8576902
[TBL] [Abstract][Full Text] [Related]
7. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group.
Amato L; Paolisso G; Cacciatore F; Ferrara N; Ferrara P; Canonico S; Varricchio M; Rengo F
Diabetes Metab; 1997 Jun; 23(3):213-8. PubMed ID: 9233998
[TBL] [Abstract][Full Text] [Related]
8. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
Vaag A
Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
[TBL] [Abstract][Full Text] [Related]
9. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk].
Samuelsson O; Pennert K; Andersson O; Berglund G; Hedner T; Persson B; Wedel H; Wilhelmsen L
Lakartidningen; 1998 Mar; 95(11):1120-3. PubMed ID: 9542820
[TBL] [Abstract][Full Text] [Related]
10. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome' in a middle-aged Finnish population.
Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Takala JK
J Cardiovasc Risk; 1997 Aug; 4(4):291-5. PubMed ID: 9477208
[TBL] [Abstract][Full Text] [Related]
12. Metabolic predictors of hypertension.
Haffner SM
J Hypertens Suppl; 1999 Aug; 17(3):S23-8. PubMed ID: 10489095
[TBL] [Abstract][Full Text] [Related]
13. Abdominal fat distribution and insulin levels only partially explain adverse cardiovascular risk profile in Asian Indians.
Hodge AM; Dowse GK; Collins VR; Alberti KG; Gareeboo H; Tuomilehto J; Zimmet PZ
J Cardiovasc Risk; 1996 Jun; 3(3):263-70. PubMed ID: 8863097
[TBL] [Abstract][Full Text] [Related]
14. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
Haffner SM; Gonzalez C; Mykkänen L; Stern M
Diabetologia; 1997 Jul; 40(7):830-7. PubMed ID: 9243105
[TBL] [Abstract][Full Text] [Related]
15. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
Hadaegh F; Zabetian A; Harati H; Azizi F
Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
17. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
[TBL] [Abstract][Full Text] [Related]
18. The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance.
Kritz-Silverstein D; Barrett-Connor E; Wingard DL
N Engl J Med; 1989 Nov; 321(18):1214-9. PubMed ID: 2797087
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec.
Delisle HF; Ekoé JM
CMAJ; 1993 Jan; 148(1):41-7. PubMed ID: 8439889
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hypertensive factor and non-insulin-dependent diabetes mellitus.
Ho MS; Lewanczuk RZ; Teh BH; Lee SC; Pang PK
J Cardiovasc Pharmacol; 1994; 23 Suppl 2():S31-4. PubMed ID: 7518543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
